We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Essential Properties Realty Trust
EPRT
$6.53B
| $223K | ﹤0.01% |
8,706
-1,351
| -13% | -$31.3K |
|
2177
Boston Omaha
BOC
$429M
| $222K | ﹤0.01% |
+14,096
| New | +$214K |
|
2178
iRadimed
IRMD
$1.15B
| $222K | ﹤0.01% |
4,667
-5,096
| -52% | -$214K |
|
2179
DoubleVerify
DV
$2.03B
| $221K | ﹤0.01% |
6,006
-28,384
| -83% | -$884K |
|
2180
Vanguard Information Technology ETF
VGT
$147B
| $221K | ﹤0.01% |
+3,648
| New | +$203K |
|
2181
Entegris
ENTG
$22B
| $220K | ﹤0.01% |
+1,836
| New | +$186K |
|
2182
Tango Therapeutics
TNGX
$4.51B
| $220K | ﹤0.01% |
+22,176
| New | +$192K |
|
2183
Clarivate
CLVT
$1.21B
| $218K | ﹤0.01% |
23,536
+7,392
| +46% | +$54.6K |
|
2184
HNI Corp
HNI
$3.54B
| $218K | ﹤0.01% |
5,204
-27,181
| -84% | -$1.03M |
|
2185
PagSeguro Digital
PAGS
$2.54B
| $216K | ﹤0.01% |
+17,330
| New | +$159K |
|
2186
LXP Industrial Trust
LXP
$3.58B
| $215K | ﹤0.01% |
4,341
-4,811
| -53% | -$210K |
|
2187
Comtech Telecommunications
CMTL
$51.5M
| $215K | ﹤0.01% |
25,490
+14,558
| +133% | +$152K |
|
2188
Albany International
AIN
$1.73B
| $215K | ﹤0.01% |
+2,185
| New | +$191K |
|
2189
Integer Holdings
ITGR
$4.25B
| $215K | ﹤0.01% |
2,166
-10,171
| -82% | -$875K |
|
2190
Ionis Pharmaceuticals
IONS
$9.46B
| $214K | ﹤0.01% |
+4,300
| New | +$206K |
|
2191
Protagonist Therapeutics
PTGX
$9.71B
| $214K | ﹤0.01% |
9,342
-1,124
| -11% | -$19.7K |
|
2192
TriCo Bancshares
TCBK
$1.82B
| $213K | ﹤0.01% |
4,965
-3,960
| -44% | -$142K |
|
2193
Vanguard Russell 1000 ETF
VONE
$8.68B
| $213K | ﹤0.01% |
+980
| New | +$199K |
|
|
AIV
2194
Aimco
AIV
$377M
| $211K | ﹤0.01% |
27,003
-16,891
| -38% | -$114K |
|
2195
Acadia Healthcare
ACHC
$2.96B
| $211K | ﹤0.01% |
2,717
-5,210
| -66% | -$386K |
|
2196
Neogen
NEOG
$2.49B
| $210K | ﹤0.01% |
+10,467
| New | +$177K |
|
|
CMBM
2197
DELISTED
Cambium Networks
CMBM
| $210K | ﹤0.01% |
+35,026
| New | +$172K |
|
|
FBMS
2198
DELISTED
The First Bancshares, Inc.
FBMS
| $210K | ﹤0.01% |
+7,158
| New | +$191K |
|
2199
Arcus Biosciences
RCUS
$3.66B
| $209K | ﹤0.01% |
+10,947
| New | +$175K |
|
2200
Karat Packaging
KRT
$960M
| $209K | ﹤0.01% |
+8,411
| New | +$185K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.